Validation and Correlation of High-sensitive Troponin I and Troponin T in the Emergency Department

Overview

Journal BMC Cardiovasc Disord

Publisher Biomed Central

Specialty Cardiology & Vascular Diseases

Date 2024 Oct 12

PMID 39395935

Authors

Moustafa Nseir

Arash Mokhtari

Mia Stanisic

Ulf Ekstrom

Ashkan Labaf

Affiliations

Soon will be listed here.

Abstract

Background: Troponin elevation is frequently observed in various scenarios in the Emergency Department (ED), yet there is a paucity of studies investigating simultaneously measured high-sensitivity cardiac troponin T (hs-cTnT) and troponin I (hs-cTnI) within a diverse cohort in a clinical setting.

Methods: All patients who underwent troponin testing at a single center were eligible for this study. Only patients with simultaneous samples with hs-cTnI (Siemens) and hs-cTnT (Roche) were included, regardless of chief complaint.

Results: Analysis of 1987 samples from 1134 patients showed a significant correlation between hs-cTnT and hs-cTnI (r = 0.86, p < 0.01). Of these samples, 65% exceeded the upper reference limit (URL) for hs-cTnT, and 30% for hs-cTnI with 39% who exhibited elevated hs-cTnT levels alongside normal hs-cTnI levels. The area under the curve (AUC) for acute myocardial infarction (AMI) for the index visit was 0.80 (95% CI; 0.75-0.85) for hs-cTnT and 0.87 (95% CI; 0.83-0.91) for hs-cTnI. Sensitivity and specificity were 91% and 39% for hs-cTnT, and 80% and 80% for hs-cTnI. Positive predictive value (PPV) and negative predictive value (NPV) was 9.3% and 98.5% for hs-cTnT respectively, corresponding for hs-cTnI was 21.3% and 98.3% respectively. Hazard ratios for 1-year mortality were 1.52 (95% CI; 1.40-1.66) for hs-cTnT and 1.26 (95% CI; 1.18-1.34) for hs-cTnI.

Conclusion: Elevated troponins above the URL were very common in this diverse cohort, particularly for hs-cTnT, which was twice as frequent compared to hs-cTnI, resulting in low specificity and PPV for AMI.

References

Melki D, Lugnegard J, Alfredsson J, Lind S, Eggers K, Lindahl B . Implications of Introducing High-Sensitivity Cardiac Troponin T Into Clinical Practice: Data From the SWEDEHEART Registry. J Am Coll Cardiol. 2015; 65(16):1655-1664. DOI: 10.1016/j.jacc.2015.02.044. View

Park K, Gaze D, Collinson P, Marber M . Cardiac troponins: from myocardial infarction to chronic disease. Cardiovasc Res. 2017; 113(14):1708-1718. PMC: 5852618. DOI: 10.1093/cvr/cvx183. View

van der Linden N, Wildi K, Twerenbold R, Pickering J, Than M, Cullen L . Combining High-Sensitivity Cardiac Troponin I and Cardiac Troponin T in the Early Diagnosis of Acute Myocardial Infarction. Circulation. 2018; 138(10):989-999. DOI: 10.1161/CIRCULATIONAHA.117.032003. View

Espinosa A, Hussain S, Al-Awar A, Jha S, Elmahdy A, Kalani M . Differences between cardiac troponin I vs. T according to the duration of myocardial ischaemia. Eur Heart J Acute Cardiovasc Care. 2023; 12(6):355-363. DOI: 10.1093/ehjacc/zuad017. View

Wildi K, Gimenez M, Twerenbold R, Reichlin T, Jaeger C, Heinzelmann A . Misdiagnosis of Myocardial Infarction Related to Limitations of the Current Regulatory Approach to Define Clinical Decision Values for Cardiac Troponin. Circulation. 2015; 131(23):2032-40. PMC: 4456170. DOI: 10.1161/CIRCULATIONAHA.114.014129. View

Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe A, Katus H . Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2009; 56(2):254-61. DOI: 10.1373/clinchem.2009.132654. View

Januzzi Jr J, Filippatos G, Nieminen M, Gheorghiade M . Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section. Eur Heart J. 2012; 33(18):2265-71. DOI: 10.1093/eurheartj/ehs191. View

Saenger A, Beyrau R, Braun S, Cooray R, Dolci A, Freidank H . Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta. 2011; 412(9-10):748-54. DOI: 10.1016/j.cca.2010.12.034. View

Hijazi Z, Siegbahn A, Andersson U, Lindahl B, Granger C, Alexander J . Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy. Clin Chem. 2014; 61(2):368-78. DOI: 10.1373/clinchem.2014.226936. View

10.

Wu A, Feng Y . Biochemical differences between cTnT and cTnI and their significance for diagnosis of acute coronary syndromes. Eur Heart J. 1998; 19 Suppl N:N25-9. View

11.

Chapman A, Fujisawa T, Lee K, Andrews J, Anand A, Sandeman D . Novel high-sensitivity cardiac troponin I assay in patients with suspected acute coronary syndrome. Heart. 2018; 105(8):616-622. PMC: 6580754. DOI: 10.1136/heartjnl-2018-314093. View

12.

Newby L, Jesse R, Babb J, Christenson R, De Fer T, Diamond G . ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2012; 60(23):2427-63. DOI: 10.1016/j.jacc.2012.08.969. View

13.

Tveit S, Myhre P, Hoff N, Le T, Seljeflot I, Roysland R . Superiority of high sensitivity cardiac troponin T vs. I for long-term prognostic value in patients with chest pain; data from the Akershus cardiac Examination (ACE) 3 study. Clin Biochem. 2020; 78:10-17. DOI: 10.1016/j.clinbiochem.2019.12.016. View

14.

Badertscher P, Boeddinghaus J, Nestelberger T, Twerenbold R, Wildi K, Sabti Z . Effect of Acute Coronary Syndrome Probability on Diagnostic and Prognostic Performance of High-Sensitivity Cardiac Troponin. Clin Chem. 2018; 64(3):515-525. DOI: 10.1373/clinchem.2017.279513. View

15.

Welsh P, Preiss D, Hayward C, Shah A, McAllister D, Briggs A . Cardiac Troponin T and Troponin I in the General Population. Circulation. 2019; 139(24):2754-2764. PMC: 6571179. DOI: 10.1161/CIRCULATIONAHA.118.038529. View

16.

Brooke H, Talback M, Hornblad J, Johansson L, Ludvigsson J, Druid H . The Swedish cause of death register. Eur J Epidemiol. 2017; 32(9):765-773. PMC: 5662659. DOI: 10.1007/s10654-017-0316-1. View

17.

Cardinaels E, Daamen M, Bekers O, Ten Kate J, Niens M, van Suijlen J . Clinical Interpretation of Elevated Concentrations of Cardiac Troponin T, but Not Troponin I, in Nursing Home Residents. J Am Med Dir Assoc. 2015; 16(10):884-91. DOI: 10.1016/j.jamda.2015.06.026. View

18.

Buno Soto A, Peoch K, Fasano T, Diaz-Garzon J, Gonzalez de la Presa B, Chicha-Cattoir V . Performance evaluation of the high sensitive troponin I assay on the Atellica IM analyser. Biochem Med (Zagreb). 2022; 32(2):020709. PMC: 9195607. DOI: 10.11613/BM.2022.020709. View

19.

Boeddinghaus J, Nestelberger T, Twerenbold R, Koechlin L, Meier M, Troester V . High-Sensitivity Cardiac Troponin I Assay for Early Diagnosis of Acute Myocardial Infarction. Clin Chem. 2019; 65(7):893-904. DOI: 10.1373/clinchem.2018.300061. View

20.

Vestergaard K, Jespersen C, Arnadottir A, Soletormos G, Schou M, Steffensen R . Prevalence and significance of troponin elevations in patients without acute coronary disease. Int J Cardiol. 2016; 222:819-825. DOI: 10.1016/j.ijcard.2016.07.166. View